journal article·2016-01

Synthesis and characterization of ZnFe2O4 nanoparticles and its biomedical applications

S. Manjura Hoque, Md. Sazzad Hossain, Shamima Choudhury, S. Akhter, F. Hyder

Materials Letters· Volume 162
Publisher page

Abstract

Biomedical applications of ZnFe2O4 nanoparticle are preferable among all kinds of ferrites due to the compatibility of Zn2+ ions for human bodies. We have followed the soft chemical route to synthesize chitosan and PEG coated ZnFe2O4 nanoparticles and also the chitosan-coated-nanoparticles encapsulated with liposome. X-ray diffraction studies by the Mo Kα target, showed the formation of single phase spinel structure. The lattice parameter turned out to be 8.48Å and grain size ~ 4.8 nm (± 0.1 nm). Similar particle size was observed by transmission electron microscope analysis. HRTEM studies showed the distinct lattice fringes thus confirming the good crystallinity of the synthesized nanoparticles. M-H curve at room temperature showed the prepared sample was superparamagnetic in nature, which is also confirmed by the doublets of Mössbauer spectroscopy. Relaxivity values (r2) of Chitosan and PEG coated ZnFe2O4 nanoparticles are 68 and 76 mM-1s-1 respectively. In order to achieve further biocompatibility the chitosan-coated-nanoparticles were encapsulated with liposome. The r2 relaxivity was found as 54mM-1s-1. MR images obtained from the in vitro experiments based on phantoms demonstrated good contrast enhancement. Induction heating of bare and coated particles was investigated to reveal the self heating temperature rising properties of ZnFe2O4 nanoparticles.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Magnetic Properties and Synthesis of Ferrites · Iron oxide chemistry and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (18)

Show source-provided references
1. Chitosan-coated nickel-ferrite nanoparticles as contrast agents in magnetic resonance imaging10.1016/j.jmmm.2014.12.077 ↗
2. Facile synthesis of zinc ferrite nanoparticles as non-lanthanide T1 MRI contrast agents10.1039/c2jm30684k ↗
3. Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging10.1016/j.biomaterials.2009.02.001 ↗
4. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity10.1021/nl102623x ↗
5. Characterization of aqueous dispersions of Fe3O4 nanoparticles and their biomedical applications10.1016/j.biomaterials.2004.03.016 ↗
6. Enhanced ferrite nanoparticles as MRI contrast agents10.1016/j.jmmm.2006.10.1188 ↗
7. Inorganic nanoparticles for MRI contrast agents10.1002/adma.200802366 ↗
8. Zinc ferrite nanoparticles as MRI contrast agents10.1039/b801041b ↗
9. Superparamagnetic behaviour and T1, T2 relaxivity of ZnFe2O4 nanoparticles for magnetic resonance imaging10.1080/14786435.2012.755271 ↗
10. Surface controlled synthesis of MFe 2 O 4 (M=Mn, Fe, Co, Ni and Zn) nanoparticles and their magnetic characteristics10.1039/C2CE25957E ↗
11. Anisotropic Shaped Iron Oxide Nanostructures: Controlled Synthesis And Proton Relaxation Shortening Effects10.1021/acs.chemmater.5b00944 ↗
12. Iron oxide nanorods as high-performance magnetic resonance imaging contrast agents10.1039/C5NR00055F ↗
13. Preparation and chracterization of manganes ferrite-besed magnetic liposomes for hyperthermia treatment of cancer10.1016/j.jmmm.2006.10.1179 ↗
14. Functionalization of cobalt ferrite nanoparticles with alginate coating for biocompatible applications
15. Structure analysis of coprecipitated ZnFe2O4 by extended x-ray-absorption fine structure10.1063/1.358255 ↗
16. Size Dependence of the Magnetic Properties in Superparamagnetic Zinc-Ferrite Nanoparticles10.3938/jkps.53.2090 ↗
17. Synthesis and characterization of Fe- and Co-based ferrite nanoparticles and study of the T 1 and T 2 relaxivity of chitosan-coated particles10.1007/s10853-012-6800-9 ↗
18. Cobalt nanoparticles as a novel magnetic resonance contrast agent – relaxivities at 1.5 and 3 Tesla10.1002/cmmi.241 ↗